DocMode launches e-dialogue series to bridge Covid-induced knowledge, relationship gap between docs and drug makersOctober 8, 2021
DocMode, India’s leading online continuing medical education (CME) company, has launched GAPSULE -– the first of its kind e-dialogue series to address the Covid-induced knowledge and relationship gap between physicians and pharmaceutical industry. The dialogue series is a novel initiative in the Indian context to find workable solutions to equip physicians with the latest information about medical development.
“Social distancing and other norms have limited the scope of physical interaction between physicians and medical representatives resulting in the knowledge and relational gap. DocMode facilitates a process to remove that barrier by bringing together different stakeholders on the GAPSULE platform,” said Hans Lewis, Founder and CEO, DocMode.
“The first session of GAPSULE saw different pharmaceutical companies coming together. They discussed knowledge and relationships, shared their experience and exchanged different ideas. The response to the first session of the dialogue series was overwhelming,” added Lewis.
Dr. Mahesh Abhyankar, Vice President, USV, and author of popular book ‘Emozeal’, noted that major hospitals became no-entry zones to medical representatives with the outbreak of the coronavirus resulting in interaction deficit which has the potential to affect treatment outcome.
“I can understand that it is a genuine concern of hospitals. But it does not mean that we should live with the issue of compromising patient satisfaction. I am happy that DocMode has taken up this initiative which is the need of the hour,” said Dr. Abhyankar.
According to Dr Abhyankar, quality patient care always depends on detailed product information, guideline-based practice and new article references based on evolving science. “We need to aid the information flow and for this what is required is digital competency, not just digital literacy,” he added.
“In this transitional phase, doctors prefer to meet companies who add value to their practice and patients. GAPSULE will help this transition,” said Akumentis Healthcare’s SBU Head (Sales & Marketing), Subhojit Mukherjee, who feels that customer relation has been evolving into customer value.
Nikhil Dhamne, Business Unit Head, Sun Pharma Laboratories, believes that visibility factor is important for physicians as well as pharmaceutical companies. “Visibility is not about showing a brand or my face, it is the uninterrupted passage of information,” he said.
GAPSULE, according to Dhamane, is an initiative whose aim is to ensure information flow. “With adequate information, doctors can make informed decisions keeping patient-safety and well-being,” he added.
“It is worth exploring alternative forms of interaction for information flow when the conservative approach of physical interactions finds roadblocks due to a variety of reasons including a pandemic-like situation. DocMode is committed to provide the latest technology for physicians and pharmaceutical companies to promote the cause of continuing medical education and GAPSULE is just one of our tools in this context,” said Lewis.
The upcoming GAPSULE sessions would be more interesting since they would involve physicians, pharmaceutical companies and even other stakeholders. Hopefully, we should succeed in finding a solution that is best-suited for all, he added.